INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 134 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,238,000 | +11.2% | 101,665 | +4.1% | 0.00% | 0.0% |
| Q4 2018 | $1,113,000 | -70.2% | 97,677 | -43.2% | 0.00% | 0.0% |
| Q3 2018 | $3,730,000 | +59.3% | 171,924 | +29.8% | 0.00% | -50.0% |
| Q2 2018 | $2,341,000 | -49.4% | 132,500 | -39.7% | 0.00% | -33.3% |
| Q1 2018 | $4,624,000 | +82.9% | 219,673 | +25.8% | 0.00% | +50.0% |
| Q4 2017 | $2,528,000 | +48.1% | 174,620 | +61.5% | 0.00% | +100.0% |
| Q3 2017 | $1,707,000 | +23.9% | 108,156 | -2.5% | 0.00% | 0.0% |
| Q2 2017 | $1,378,000 | -39.5% | 110,925 | -20.8% | 0.00% | -50.0% |
| Q1 2017 | $2,276,000 | +6.0% | 140,080 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $2,147,000 | -5.4% | 142,259 | -4.5% | 0.00% | +100.0% |
| Q3 2016 | $2,270,000 | -61.3% | 148,931 | -1.5% | 0.00% | -80.0% |
| Q2 2016 | $5,872,000 | +68.3% | 151,266 | +20.5% | 0.01% | +66.7% |
| Q1 2016 | $3,489,000 | -41.2% | 125,515 | +13.8% | 0.00% | -25.0% |
| Q4 2015 | $5,931,000 | +68.4% | 110,270 | +25.3% | 0.00% | +33.3% |
| Q3 2015 | $3,523,000 | +16.7% | 87,986 | -6.9% | 0.00% | +50.0% |
| Q2 2015 | $3,020,000 | +96.1% | 94,514 | +46.6% | 0.00% | +100.0% |
| Q1 2015 | $1,540,000 | +31.2% | 64,489 | -3.1% | 0.00% | 0.0% |
| Q4 2014 | $1,174,000 | +32.4% | 66,522 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $887,000 | -18.7% | 64,725 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,091,000 | – | 64,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |